Literature DB >> 4847254

Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs.

J H Walsh, H T Debas, M I Grossman.   

Abstract

Biological properties of pure natural human "big gastrin" (designated G-34 because it contains 34 amino acid residues) were compared with those of pure natural heptadecapeptide gastrins (G-17) from human and porcine sources. Radioimmunoassay inhibition curves indicated that G-17 was nearly 1.5 times more potent than G-34 with the antibody used in this study. This difference was confirmed by demonstration of increased immunoreactivity generated when G-34 was converted to G-17 by trypsinization. When infused intravenously into dogs with gastric fistulas and Heidenhain pouches in equimolar doses, G-34 produced slightly higher acid secretory responses than G-17. Responses to sulfated and nonsulfated forms were not significantly different, nor were responses to human and porcine G-17. During infusion of equimolar doses, steady-state serum gastrin concentrations were more than fivefold higher with G-34 than with G-17. The difference in steady-state blood concentrations could be accounted for by a corresponding difference in removal rates. The half times of the G-34 preparations averaged 15.8 min and the half times of the G-17 preparations averaged 3.2 min. The calculated spaces of distribution for G-17 and G-34 were similar, about 25% of body weight. When the increment in serum gastrin was plotted against acid secretory response it was found that nearly five times greater increments in molar concentrations of G-34 than of G-17 were required to produce the same rate of acid secretion. The potency of these two molecular forms of gastrin can be expressed in two different ways. Based on exogenous molar doses, the potencies of G-34 and G-17 were similar. However, based on molar increments in serum gastrin concentration, G-17 was approximately five times more potent than G-34. Hence, fractionation of these gastrin components may be important in estimation of the acid-stimulating action represented by total serum gastrin as measured by radio-immunoassay.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4847254      PMCID: PMC301575          DOI: 10.1172/JCI107783

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Isolation of two "big gastrins" from Zollinger-Ellison tumour tissue.

Authors:  R A Gregory; H J Tracy
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

2.  Rate and pattern of disappearance of exogenous gastrin in dogs.

Authors:  D D Reeder; B M Jackson; E N Brandt; J C Thompson
Journal:  Am J Physiol       Date:  1972-06

3.  Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome.

Authors:  J I Isenberg; J H Walsh; E Passaro; E W Moore; M I Grossman
Journal:  Gastroenterology       Date:  1972-04       Impact factor: 22.682

4.  Relationships of gastrin dose, serum gastrin, and acid secretion.

Authors:  J E McGuigan; J Isaza; J H Landor
Journal:  Gastroenterology       Date:  1971-11       Impact factor: 22.682

5.  Size and charge distinctions between endogenous human plasma gastrin in peripheral blood and heptadecapeptide gastrins.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1970-05       Impact factor: 22.682

6.  Radioimmunoassay of gastrin.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1970-01       Impact factor: 22.682

7.  Nature of immunoreactive gastrin extracted from tissues of gastrointestinal tract.

Authors:  S A Berson; R S Yllow
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

8.  Further studies on the nature of immunoreactive gastrin in human plasma.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

9.  Aminoacid constitution of two gastrins isolated from Zollinger-Ellison tumour tissue.

Authors:  R A Gregory; H J Tracy; K L Agarwal; M I Grossman
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

10.  Studies with antibodies to gastrin. Radioimmunoassay in human serum and physiological studies.

Authors:  J E McGuigan; W L Trudeau
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

View more
  35 in total

Review 1.  Topical review. Gastrin and gastric epithelial physiology.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

2.  Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Authors:  C G Blackmore; A Varro; R Dimaline; L Bishop; D V Gallacher; G J Dockray
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

3.  Letter: Gastrin heterogeneity: simple or complex?

Authors:  N S Track; J S Rehfeld
Journal:  Br Med J       Date:  1975-04-19

4.  Head movement during low-frequency vibration.

Authors:  J Sandover; R W Soames
Journal:  J Physiol       Date:  1975-05       Impact factor: 5.182

5.  pH dependence of acid secretion and gastrin release in normal and ulcer subjects.

Authors:  J H Walsh; C T Richardson; J S Fordtran
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Editorial: Gastrin heterogeneity.

Authors: 
Journal:  Br Med J       Date:  1975-01-18

7.  Effect of secretin on release of heterogeneous forms of gastrin.

Authors:  E Straus; A J Greenstein; R S Yalow
Journal:  Gut       Date:  1975-12       Impact factor: 23.059

8.  Relative abundance of big and little gastrins in the tumours and blood of patients with the Zollinger Ellison syndrome.

Authors:  G J Dockray; J H Walsh; E Passaro
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

9.  Gastrins in cat and dog: evidence for a biosynthetic relationship between the large molecular forms of gastrin and heptadecapeptide gastrin.

Authors:  J F Rehfield; K Uvnäs-Wallensten
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

10.  Pathways of processing of the gastrin precursor in rat antral mucosa.

Authors:  A Varro; S Voronina; G J Dockray
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.